首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Purification of recombinant trichodysplasia spinulosa-associated polyomavirus VP1-derived virus-like particles using chromatographic techniques
【24h】

Purification of recombinant trichodysplasia spinulosa-associated polyomavirus VP1-derived virus-like particles using chromatographic techniques

机译:使用色谱技术纯化重组序列胰蛋白酶分子瘤相关的多瘤VP1衍生的病毒样颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

Trichodysplasia spinulosa-associated polyomavirus (TSPyV) has been linked to a rare and recently characterized skin disease occurring in immunocompromised patients. In analogy with other polyomaviruses, the major capsid protein VP1 of TSPyV can self-assemble into virus-like particles (VLPs). VLPs are increasingly applied for the vaccination and diagnostics. Mostly, non-scalable and labor intensive ultracentrifugation-based techniques are used for the purification of VLPs. In this work, we developed a purification procedure for TSPyV VP1 VLPs based on two chromatographic steps, ion-exchange monolith and core bead chromatography. Prior to chromatography, ammonium sulfate precipitation was used for the initial purification of TSPyV VP1 VLPs from yeast lysate. The VLPs were further purified using CIMmultus QA ion-exchange monolith in bind-elute mode. Most of TSPyV VP1 VLPs bound to the monolith and were subsequently eluted by a linear NaCl gradient. After ion-exchange monolith chromatography, the purity of TSPyV VP1 protein was about 75%. The final purification step of TSPyV VP1 VLPs was core bead chromatography using Capto Core 700 resin in flow-through mode. After core bead chromatography, 42% of TSPyV VP1 protein was recovered with a purity of 93%. The assembly of purified TSPyV VP1 protein into VLPs approximately 45-50 nm in diameter was confirmed by electron microscopy analysis. The purification procedure for TSPyV VP1 VLPs described here could be a scalable alternative to the conventional ultracentrifugation-based purification methods.
机译:Trichodysplasia Spinulosa相关的多瘤病毒(TSPYV)已与免疫疗效患者发生的稀有和最近特征的皮肤病有关。与其他多聚瘤类似,TSPYV的主要衣壳蛋白VP1可以自组装成病毒样颗粒(VLP)。 VLP越来越多地应用于疫苗接种和诊断。主要是,基于非可扩展性和劳动密集型超速离心的技术用于纯化VLP。在这项工作中,我们基于两种色谱步骤,离子交换整体和芯珠色谱法为TSPYV VP1 VLP进行了净化程序。在色谱法之前,硫酸铵沉淀用于从酵母裂解物中初始纯化TspyV VP1 VLP。使用CIMMULTUSQA离子交换整料进一步纯化VLP,以结合洗脱模式。 TSPYV VP1 VLP的大多数与整料结合,随后被线性NaCl梯度洗脱。离子交换整料色谱后,TSPYV VP1蛋白的纯度约为75%。 TSPYV VP1 VLP的最终纯化步骤是在流通模式下使用CAPTO核心700树脂的核心珠色谱。在核珠色谱后,回收42%的TSPYV VP1蛋白质,纯度为93%。通过电子显微镜分析证实纯化的TSPYV VP1蛋白的组装成大约45-50nm的VLP。这里描述的TSPYV VP1 VLP的纯化步骤可以是常规超速离心的纯化方法的可扩展替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号